Drug
Aumolertinib Midazolam
Aumolertinib Midazolam: highest development phase Phase 1, developed by Hansoh Pharmaceutical. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Hansoh Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| Aumolertinib；midazolam NCT06926413 | Phase 1 | Non Small Cell Lung Cancer |
Latest
No recent events.
Follow Aumolertinib Midazolam on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.